Blueprint Medicines raised $50,000,000 on , from Cowen Investments, Partner Fund ....

Get alertedif Blueprint Medicines gets funded!
Amount:$50,000,000
Company:
Investors:, , , , , , ,
Industry:Biotechnology
Country:
State:
City:
United States
Massachusetts
Cambridge
Key people:Alexis Borisy (Co - Founder & Board Director, Co - Founder & Board of Directors)
Giulio Draetta (Scientific Advisor)
Kyle Kuvalanka (Chief Business Officer)
Christoph Lengauer (Chief Scientific Officer)
Daniel Lynch (Board Member, Executive Chairman)
Deborah Palestrant (Strategic Planning and Operations)
Chris Varma (President & CEO)
Data sources:
www.prnewswire.com - RT @AndyBiotech: Congrats! -> @BlueprintMeds Secures $50M in Series C Round http://t.co/r3FlOX241B KIT D816V Selective Inhibitor & FGFR4 S…
www.biospace.com - RT @Pharmaceutical: MA's Blueprint Medicines Scrounges Up $50 Million: Blueprint Medicines Secures $50 Million in Series C Financi... http:…
m.newslocker.com - Blueprint Medicines Secures $50 Million in Series C Financing #NewsSales http://t.co/DUOIET7ACN
bostonbiotech.org - @Blueprintmeds closes $50 million Series C. Worried about finding money for your company? Come to BCB's launch event: http://t.co/zEgrpXp4G5
www.massbio.org - Blueprint Medicines Secures $50 Million in Series C Financing: Proceeds to support continued advancement of hi... http://t.co/kicuceB5tr
pevc.dowjones.com - Blueprint Medicines Raises $50M Financing for Genomically Targeted Cancer Drugs http://t.co/ISf8u4Z5ZS
www.vcaonline.com - Blueprint Medicines Secures $50 Million in Series C Financing http://t.co/t77ttm7auh http://t.co/YVR2MMWR6L
www.biocentury.com - Blueprint raises $50 million in series C http://t.co/kfiw4ZA5qI Blueprint Medicines (Cambridge, Mass.) raised $50 million in an untranc...
zipzp.eu - Blueprint Medicines Raises $50M Financing for Genomically ... http://t.co/V4DbJG1GWl
www.fiercebiotech.com - Blueprint Medicines Secures $50 Million in Series C Financing - FierceBiotech: http://t.co/cIGZgrikJk
www.finsmes.com - . @BlueprintMeds, a developer of selective #kinase inhibitors, has raised $50m led by Partner Fund Management. http://t.co/m1mkTHg25e
www.vcnewsdaily.com - Blueprint Medicines Secures $50M in Series C http://t.co/1eJbN9GFE9 http://t.co/t6qgQ8XG4V
www.levinassociates.com - Blueprint Medicines secures $50 million in Series C financing. http://t.co/jh6z8iTE11
Description:
Blueprint Medicines, a Biotechnology-specialized company based in Cambridge, United States, closed on a 50M financing round in November 12th, 2014.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!